Filtered By:
Vaccination: Meningitis Vaccine

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 2891 results found since Jan 2013.

Pneumococcal Vaccination in Rheumatology: Utilizing Nurse-Driven Protocol For Pneumococcal Vaccination in an Academic Rheumatology Clinic
CONCLUSION: It is feasible to employ a nurse-driven protocol for improving pneumococcal vaccination rates in immunosuppressed patients, despite difficulties posed by COVID-19 pandemic disruptions.PMID:36319017 | DOI:10.3899/jrheum.220771
Source: J Rheumatol - November 1, 2022 Category: Rheumatology Authors: Elena K Joerns Nagendra Pokala Bonnie Bermas Joan Reisch Dan Clarie Wang Reuben Arasaratnam Puneet Bajaj Source Type: research

Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?
CONCLUSIONS: Overall, PCV13 demonstrated better protection than PPV23 against pneumococcal disease and all-cause respiratory outcomes in the included studies. Where evaluated, sequential PCV13/PPV23 vaccination showed little benefit over PCV13 alone. Results support the use of PCVs to protect against pneumococcal disease and respiratory infections in adults.PMID:36681604 | DOI:10.1016/j.arbres.2022.12.015
Source: Archivos de Bronconeumologia - January 21, 2023 Category: Respiratory Medicine Authors: Eileen M Dunne Catia Cilloniz Claire von Mollendorf Joseph Lewnard Lindsay R Grant Mary P E Slack Luis Jodar Christian Theilacker Bradford D Gessner Source Type: research

Exclusion of older adults and immunocompromised  individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
CONCLUSIONS: During the COVID-19 pandemic, we found a decrease in the exclusion of older adults from vaccine trials but no significant change in the inclusion of immunocompromised individulas.PMID:37027085 | DOI:10.1007/s40520-023-02380-4
Source: Aging Clinical and Experimental Research - April 7, 2023 Category: Geriatrics Authors: Katrine Bukan Toby Pearce-Slade Mads Eiberg Marco Tinelli Dafna Yahav Jose Tuells Olivier Epaulard Jon G Holler Casper Roed Christian S øborg Jens-Ulrik St æhr Jensen Zitta Barrella Harboe Source Type: research

Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65  years: a systematic review
Geroscience. 2023 Jun 3. doi: 10.1007/s11357-023-00807-4. Online ahead of print.ABSTRACTThis systematic review aims to summarize the impact of vaccination against influenza, shingles, and pneumococcus on the incidence on the risk of cardiovascular events in the elderly. This protocol was developed in accordance with PRISMA guidelines. We conducted a literature search and identified all relevant articles published regarding the matter up to September 2022. We retrieved 38 studies (influenza vaccine = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal...
Source: Herpes - June 3, 2023 Category: Infectious Diseases Authors: Alexandra Addario Thomas C élarier Bienvenu Bongue Nathalie Barth Ga ëtan Gavazzi Elisabeth Botelho-Nevers Source Type: research

The Impact of 7-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review.
CONCLUSIONS: The results from this review illustrate that PCV7 has had a significant impact on IPD across all ages through its use in pediatric immunization programs. With the introduction of 13-valent pneumococcal conjugate vaccine (PCV13) further reductions in the incidence of IPD due to the six additional serotypes included, as well as continued protection against IPD due to PCV7 serotypes may be expected. Robust surveillance systems are essential for the evaluation of the impact of PCV13 on all-type IPD and for monitoring the evolution of non-VT IPD. PMID: 23397399 [PubMed - as supplied by publisher]
Source: Advances in Therapy - February 7, 2013 Category: Drugs & Pharmacology Authors: Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, Sprenger R, Bonnet E Tags: Adv Ther Source Type: research

Vaccines for preventing pneumococcal infection in adults.
CONCLUSIONS: This meta-analysis provides evidence supporting the recommendation for PPV to prevent IPD in adults. The evidence from RCTs is less clear with respect to adults with chronic illness. This might be because of lack of effect or lack of power in the studies. The meta-analysis does not provide evidence to support the routine use of PPV to prevent all-cause pneumonia or mortality. PMID: 23440780 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - March 2, 2013 Category: Journals (General) Authors: Moberley S, Holden J, Tatham DP, Andrews RM Tags: Cochrane Database Syst Rev Source Type: research

Question 2 * Is there a role for MRI as an adjunct for diagnosing bacterial meningitis?
Scenario You are asked to consult on a 3-week-old neonate who was admitted for a ‘full septic screen’. He had a lumbar puncture several hours after starting antibiotics. The lumbar puncture was traumatic and revealed pleocytosis (increased red and white cells). Cultures remained sterile after 72 h, but there was concern that the antibiotics had caused a false negative culture result. You wonder if in this scenario MRI would be useful to aid diagnosis of meningitis. Structured clinical question In a 3-week-old neonate with suspected meningitis [patient], does MRI [intervention] assist in the diagnosis of ba...
Source: Archives of Disease in Childhood - April 12, 2013 Category: Pediatrics Authors: Upadhyayula, S. Tags: ADC Archimedes, Immunology (including allergy), Drugs: infectious diseases, Meningitis, Vaccination / immunisation, Infection (neurology) Source Type: research

Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention
Conclusions: Increased awareness of the public health and economic benefits of pneumococcal vaccination is critically needed to help both the public and policymakers in making changes to vaccination policies in the region. Maximizing access to pneumococcal vaccines will decrease the number of hospitalizations, complications, and deaths associated with pneumococcal disease.
Source: International Journal of Infectious Diseases - February 18, 2013 Category: Infectious Diseases Authors: Ivan Fan-Ngai Hung, Terapong Tantawichien, Ying Huang Tsai, Shilpa Patil, Ricardo Zotomayor Tags: Review Source Type: research

Physicians' gut feeling is useful in diagnosing serious infection in children
Commentary on: Van den Bruel A, Thompson M, Buntinx F, et al.. Clinicians’ gut feeling about serious infections in children: observational study. BMJ 2012;345:e6144. Context With the advent of effective vaccinations, serious infections (SI) have become rare among children presenting to primary care settings, yet when not diagnosed promptly, such infections, especially meningitis and septic shock, can cause substantial morbidity and mortality. Hence, researchers continue to search for new diagnostic methods; the present study by Van den Bruel and colleagues investigates the basis and value of gut feeling or intuition ...
Source: Evidence-Based Medicine - July 5, 2013 Category: Internal Medicine Authors: Mittal, M. K. Tags: Infection (gastroenterology), EBM Prognosis, Epidemiologic studies, General practice / family medicine, Immunology (including allergy), Meningitis, Pneumonia (infectious disease), Vaccination / immunisation, Infection (neurology), Renal medicine, Pneumoni Source Type: research

The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe
ConclusionDespite the heterogeneity of the studies identified, the available data show a substantial incidence of IPD in at‐risk children, particularly those who are immunocompromised. Further research is needed to determine the true risk of IPD in at‐risk children, particularly in the post‐PCV period, and to understand the benefits of vaccination and optimal vaccination schedules.
Source: International Journal of Clinical Practice - July 19, 2013 Category: Internal Medicine Authors: M. A. Rose, D. Christopoulou, T. T. H. Myint, I. Schutter Tags: Systematic Review Source Type: research

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis.
CONCLUSIONS: The results from this review demonstrate that PCV7 has had a significant impact on pneumococcal meningitis across all ages through its use in pediatric immunization programs. With the introduction of 13-valent PCV (PCV13) we can expect to see a reduction in the incidence of pneumococcal meningitis due to the six additional serotypes included, as well as continued protection against pneumococcal meningitis due to PCV7 serotypes. Robust surveillance systems are essential for the evaluation of the impact of PCV13 on all-type pneumococcal meningitis and for monitoring the evolution of non-vaccine serotype pneumoco...
Source: Advances in Therapy - September 3, 2013 Category: Drugs & Pharmacology Authors: Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E Tags: Adv Ther Source Type: research

Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: A meta-analysis.
Abstract Pneumococcal infections are a major cause of morbidity and mortality worldwide. Pneumococcal conjugate vaccines represent major progress in the prevention of invasive pneumococcal disease in the paediatric population. We performed a meta-analysis, in accordance with the PRISMA statement, in order to assess the immunogenicity and safety of 13-valent pneumococcal conjugate vaccines in infants. A literary search was conducted using electronic databases and specialized journals were searched manually. Inclusion criteria were: clinical trials with infants vaccinated with 13-valent pneumococcal conjugate, compa...
Source: Vaccine - September 18, 2013 Category: Allergy & Immunology Authors: Ruiz-Aragón J, Peláez SM, Molina-Linde JM, Grande-Tejada AM Tags: Vaccine Source Type: research

What Organisms Cause Acute Epiglottitis in the Post- H. influenza Vaccination Era?
Discussion Epiglottitis is also known as supraglottitis and is caused by inflammation of the supraglottic structures and epiglottis. Usually the cause is infectious but other trauma such as thermal injuries or ingestions can also cause the disease. Before the widespread use of its conjugated immunization, Haemophilus influenza type b was the most common cause and it was usually thought of as a pediatric disease process. In the pre-immunization time period, acute epiglottitis in children was 3.47-6.0 cases per 100,000, and in the post-immunization period has declined to 0.3-0.7 cases per 100,000. However it appears that
Source: PediatricEducation.org - October 7, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news